ASX - Delayed Quote AUD

Genetic Signatures Limited (GSS.AX)

0.4350

-0.0050

(-1.14%)

As of 12:09:43 PM GMT+10. Market Open.

We're Interested To See How Genetic Signatures (ASX:GSS) Uses Its Cash Hoard To Grow

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Simply Wall St. last month

GSS.AX
-1.14%
Investors in Genetic Signatures (ASX:GSS) have unfortunately lost 59% over the last three years

The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term...

Simply Wall St. 2 months ago

GSS.AX
-1.14%
Pleasing Signs As A Number Of Insiders Buy Genetic Signatures Stock

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Simply Wall St. 3 months ago

GSS.AX
-1.14%
Genetic Signatures Limited (ASX:GSS) is favoured by institutional owners who hold 53% of the company

Key Insights Given the large stake in the stock by institutions, Genetic Signatures' stock price might be vulnerable to...

Simply Wall St. 4 months ago

GSS.AX
-1.14%
Genetic Signatures Full Year 2024 Earnings: EPS Misses Expectations

Genetic Signatures ( ASX:GSS ) Full Year 2024 Results Key Financial Results Revenue: AU$14.3m (down 33% from FY 2023...

Simply Wall St. 7 months ago

GSS.AX
-1.14%
Genetic Signatures (ASX:GSS) shareholders have endured a 41% loss from investing in the stock three years ago

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Simply Wall St. 8 months ago

GSS.AX
-1.14%
Several Insiders Invested In Genetic Signatures Flagging Positive News

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Simply Wall St. 8 months ago

GSS.AX
-1.14%
Genetic Signatures Limited (ASX:GSS) is definitely on the radar of institutional investors who own 44% of the company

Key Insights Given the large stake in the stock by institutions, Genetic Signatures' stock price might be vulnerable to...

Simply Wall St. 9 months ago

GSS.AX
-1.14%
FDA Clearance For Gastrointestinal Parasite Detection Kit

Genetic Signatures Limited [ASX:GSS] ("GSS" or the "Company"), a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Company's EasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 automated workflow[1] for marketing and sale in the US.

PR Newswire 10 months ago

GSS.AX
-1.14%

Performance Overview

Return	GSS.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	-30.95%	-4.65%
1-Year	-37.86%	+2.20%
3-Year	-66.76%	+3.41%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Genetic Signatures Limited (GSS.AX)

We're Interested To See How Genetic Signatures (ASX:GSS) Uses Its Cash Hoard To Grow

Investors in Genetic Signatures (ASX:GSS) have unfortunately lost 59% over the last three years

Pleasing Signs As A Number Of Insiders Buy Genetic Signatures Stock

Genetic Signatures Limited (ASX:GSS) is favoured by institutional owners who hold 53% of the company

Genetic Signatures Full Year 2024 Earnings: EPS Misses Expectations

Genetic Signatures (ASX:GSS) shareholders have endured a 41% loss from investing in the stock three years ago

Several Insiders Invested In Genetic Signatures Flagging Positive News

Genetic Signatures Limited (ASX:GSS) is definitely on the radar of institutional investors who own 44% of the company

FDA Clearance For Gastrointestinal Parasite Detection Kit

Performance Overview